Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
6.77
+0.13 (1.96%)
At close: Aug 11, 2026, 4:00 PM EDT
6.80
+0.03 (0.44%)
After-hours: Aug 11, 2026, 4:14 PM EDT

Exagen Revenue

Exagen had revenue of $19.94M in the quarter ending June 30, 2026, with 15.92% growth. This brings the company's revenue in the last twelve months to $71.12M, up 20.83% year-over-year. In the year 2025, Exagen had annual revenue of $66.58M with 19.65% growth.

Revenue (ttm)
$71.12M
Revenue Growth
+20.83%
P/S Ratio
2.31
Revenue / Employee
$323,282
Employees
220
Market Cap
164.01M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202566.58M10.93M19.65%
Dec 31, 202455.64M3.09M5.89%
Dec 31, 202352.55M6.99M15.33%
Dec 31, 202245.56M-2.74M-5.66%
Dec 31, 202148.30M6.32M15.07%
Dec 31, 202041.98M1.59M3.93%
Dec 31, 201940.39M7.95M24.50%
Dec 31, 201832.44M5.63M21.01%
Dec 31, 201726.81M8.86M49.38%
Dec 31, 201517.95M6.28M53.87%
Dec 31, 201411.66M8.61M281.77%
Dec 31, 20133.06M2.13M229.91%
Dec 31, 2012926.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Myriad Genetics806.60M
OPKO Health587.90M
Castle Biosciences357.28M
Fulgent Genetics323.93M
MDxHealth110.97M
Biodesix102.94M
Burning Rock Biotech74.58M
Freenome34.24M
Revenue Rankings